Yahoo Finance is in Davos! Get the latest updates here

Premier Biomedical, Inc. (BIEI)

Other OTC - Other OTC Delayed Price. Currency in USD

Add to watchlist

0.0017

0.0000

(0.00%)

As of 03:34PM EDT. Market open.

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	0.0017
Open	0.0015
Bid	0.0000 x 0
Ask	0.0000 x 0
Day's Range	0.0017 - 0.0017
52 Week Range	0.0012 - 0.0072
Volume	638,524
Avg. Volume	5,385,368

Market Cap	1.7M
Beta (5Y Monthly)	-4.94
PE Ratio (TTM)	N/A
EPS (TTM)	-0.0070
Earnings Date	Nov 02, 2020 - Nov 03, 2020
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for BIEI

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

PREMIER BIOMEDICAL INC
Technical Assessment: Neutral in the Intermediate-TermWe are raising our intermediate-term technical outlook to neutral from bearish. This reverses our April 22 intermediate-term downgrade from neutral to bearish. This action is not a green light and we are not saying the bottom is in and it's up, up, and away from here. But we do think the major indices are attempting to hammer out (via a candlestick pattern) a bottom because we have seen a few "sticks" in recent trading sessions. Simply put, we are seeing days where stocks trade significantly lower but then finish strong.
Rating
Fair Value
Economic Moat
9 hours agoArgus Research